Oh SW et al. – Erythropoietin (EPO) reduces all–cause–mortality and end stage renal disease in patients with acute kidney injury (AKI), largely due to the beneficial effect of EPO on recovery after AKI. [more...]
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close